DocGo Inc. Q2 2026 Earnings Call Summary
In its second-quarter earnings call for fiscal year 2026, DocGo Inc. outlined a transformational period driven by the acquisition of Hicuity Health, marking the company's largest deal to date. The move aims to integrate hospital and home care services through a vertically aligned platform that connects clinicians with patients across all stages of treatment. Despite challenges from winding down migrant-related projects, core business lines saw 19% year-over-year revenue growth. Operational improvements were highlighted by cost-cutting measures including layoffs that saved $4.5 million annually in SG&A expenses. The company also deployed over ten AI efficiency programs, with mobile phlebotomy being a key area where AI now handles all outbound and most inbound scheduling calls. Non-migrant health revenues surged 78% due to increased care gap closures and remote patient monitoring. DocGo expects positive adjusted EBITDA by year-end despite widening full-year loss guidance. Revenue is projected between $305 million-$310 million for the year, excluding Hicuity contributions. The company anticipates cost synergies from combining operations across 30 states and plans to launch additional efficiency programs in late 2026.
Tickers: $DCGO
Topics: acquisition ai_integration cost_reduction revenue_growth